Production (Stage)
Amicus Therapeutics, Inc.
FOLD
$6.22
-$0.04-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 250.57M | 249.95M | 249.76M | 260.06M | 239.60M |
| Total Receivables | 88.32M | 101.10M | 98.07M | 85.17M | 76.43M |
| Inventory | 132.41M | 118.78M | 115.34M | 81.32M | 60.76M |
| Prepaid Expenses | 39.49M | 34.91M | 35.31M | 35.15M | 54.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 510.80M | 504.74M | 498.47M | 461.70M | 431.24M |
|
|
|||||
| Total Current Assets | 510.80M | 504.74M | 498.47M | 461.70M | 431.24M |
| Net Property, Plant & Equipment | 50.86M | 51.66M | 53.58M | 53.77M | 55.42M |
| Long-term Investments | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Goodwill | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Total Other Intangibles | 16.39M | 17.20M | 18.03M | 18.85M | 19.67M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.00M | 13.64M | 18.68M | 17.36M | 17.66M |
| Total Assets | 789.84M | 785.03M | 786.56M | 749.48M | 721.79M |
|
|
|||||
| Total Accounts Payable | 14.45M | 12.95M | 13.48M | 32.06M | 9.21M |
| Total Accrued Expenses | 129.88M | 100.49M | 132.89M | 125.64M | 124.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.56M | 8.46M | 8.54M | 8.11M | 8.27M |
| Total Finance Division Other Current Liabilities | -- | 26.81M | 3.23M | 2.26M | -- |
| Total Other Current Liabilities | -- | 26.81M | 3.23M | 2.26M | -- |
| Total Current Liabilities | 152.89M | 148.70M | 158.14M | 168.07M | 142.10M |
|
|
|||||
| Total Current Liabilities | 152.89M | 148.70M | 158.14M | 168.07M | 142.10M |
| Long-Term Debt | 390.71M | 390.11M | 389.49M | 388.94M | 388.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.20M | 45.08M | 46.62M | 47.01M | 47.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.49M | 7.10M | 13.48M | 12.95M | 12.77M |
| Total Liabilities | 596.28M | 590.99M | 607.73M | 616.96M | 591.10M |
|
|
|||||
| Common Stock & APIC | 2.94B | 2.93B | 2.91B | 2.87B | 2.86B |
| Retained Earnings | -2.76B | -2.74B | -2.75B | -2.75B | -2.73B |
| Treasury Stock & Other | 12.74M | 5.17M | 25.04M | 8.87M | 6.72M |
| Total Common Equity | 193.56M | 194.05M | 178.83M | 132.52M | 130.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 193.56M | 194.05M | 178.83M | 132.52M | 130.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 193.56M | 194.05M | 178.83M | 132.52M | 130.69M |
|
|
|||||